pregabalin mylan pharma
mylan s.a.s. - pregabalin - anxiety disorders; neuralgia; epilepsy - antiepileptice, - epilepsypregabalin mylan pharma este indicat ca tratament adjuvant, la adulții cu convulsii parțiale cu sau fără generalizare secundară. anxietate generalizată disorderpregabalin mylan pharma este indicat pentru tratamentul tulburării anxioase generalizate (tag) la adulți.
tobradex
alcon-couvreur n.v. - belgia - combinatii (tobramycinum+dexamethasonum) - picaturi oft., susp. - 3mg/1mg/ml - antiinflamatoare si antiinfectioase in combinatie corticosteroizi si antiinfectioase in combinatie
tobradex
alcon-couvreur n.v. - belgia - combinatii (tobramycinum+dexamethasonum) - ung. oft. - 3mg/1mg/g - antiinflamatoare si antiinfectioase in combinatie corticosteroizi si antiinfectioase in combinatie
maxidex 1 mg/ml
alcon-couvreur n.v. - belgia - dexamethasonum - pic. oft., susp. - 1mg/ml - antiinflamatoare corticosteroizi
maxitrol
alcon couvreur nv - belgia - combinatii (neomycinum+dexamethasonum+polimyxynum) - picaturi oft., susp. - 3500ui+1 mg+6000ui/1ml - antiinflamatoare si antiinfectioase in combinatie corticosteroizi si antiinfectioase in combinatie
vigamox 5 mg/ml
novartis farmaceutica, s.a. - spania - moxifloxacinum - pic. oft., sol. - 5mg/ml - antiinfectioase antiinfectioase
celsunax
pinax pharma gmbh - ioflupan (123i) - radionuclide imaging; dementia; movement disorders - produse radiofarmaceutice de diagnosticare - acest medicament este destinat exclusiv diagnosticului. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. la pacienții adulți, pentru a diferenția demența cu corpi lewy de boala alzheimer. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.
jansitin 25 mg
laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 25mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
jansitin 50 mg
laboratorios liconsa s.a. - spania - sitagliptinum - compr. film. - 50mg - analogi ai glp-1 inhibitori ai dipeptidil peptidazei 4 (dpp-4)
belara
gedeon richter plc. - ungaria - combinatii (clormadinona+etinilestradiol) - compr. film. - contraceptive hormonale pentru uz sistemic progesteroni si estrogeni combinatii fixe